Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market (2025-2031) | Competitive Landscape, Segmentation, Outlook, Companies, Forecast, Industry, Growth, Share, Size & Revenue, Value, Trends, Analysis

Market Forecast By Biomarker Type (Serum Biomarkers, Biomarker Panels, Fibrosis Biomarkers, Imaging Biomarkers, Others), By End User (Hospitals, Diagnostic Centers, Others) And Competitive Landscape
Product Code: ETC7376018 Publication Date: Sep 2024 Updated Date: Oct 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Grenada Non-alcoholic Steatohepatitis (Nash) Biomarkers Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Grenada`s import shipments of non-alcoholic steatohepatitis (NASH) biomarkers saw significant growth in 2024, with top exporting countries including India, Saint Lucia, Barbados, Ireland, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) indicated a shift from high to moderate concentration in 2024, reflecting a more diversified market. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 4.45%, with a notable growth rate of 29.86% from 2023 to 2024, signaling a rapidly expanding market for NASH biomarkers in Grenada.

Key Highlights of the Report:

  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Outlook
  • Market Size of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2024
  • Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenues & Volume for the Period 2021- 2031
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trend Evolution
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers and Challenges
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Porter's Five Forces
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Life Cycle
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Type for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Serum Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Panels for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Fibrosis Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Imaging Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Diagnostic Centers for the Period 2021- 2031
  • Historical Data and Forecast of Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Import Export Trade Statistics
  • Market Opportunity Assessment By Biomarker Type
  • Market Opportunity Assessment By End User
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Top Companies Market Share
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Competitive Benchmarking By Technical and Operational Parameters
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Company Profiles
  • Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

3.1 Grenada Country Macro Economic Indicators

3.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle

3.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces

3.5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F

3.6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Grenada

4.2.2 Growing awareness about the importance of early detection and diagnosis of NASH

4.2.3 Technological advancements in biomarker development for NASH

4.3 Market Restraints

4.3.1 Limited access to healthcare services in Grenada

4.3.2 High cost associated with biomarker testing for NASH

4.3.3 Lack of standardized guidelines for NASH diagnosis and treatment in Grenada

5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends

6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types

6.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type

6.1.1 Overview and Analysis

6.1.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F

6.1.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F

6.1.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F

6.1.5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F

6.1.6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F

6.1.7 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User

6.2.1 Overview and Analysis

6.2.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

6.2.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

7 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics

7.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries

7.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries

8 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators

8.1 Number of research studies conducted on NASH biomarkers in Grenada

8.2 Adoption rate of NASH biomarker testing by healthcare providers in Grenada

8.3 Rate of incorporation of NASH biomarkers in clinical practice in Grenada

9 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment

9.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F

9.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F

10 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape

10.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024

10.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All